2023 Individual Provider Specialization 
Annals of Family Medicine
NOVEMBER 20, 2024
Unfortunately, most individuals suffering from OUD do not have access to necessary care. A critical shortage of clinicians who specialize in treating patients with OUD exacerbates this issue. Intervention: 12 monthly online OUD sessions held from April 2023 to March 2024.
Physician's Weekly
JUNE 19, 2025
When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. The insurer not only stopped paying current claims but also moved to claw back tens of thousands of dollars it had paid to providers in the two years since she turned 65.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MAY 19, 2023
In this blog we examine the Special Controls put in place to mitigate false results, incorrect interpretation of results, and incorrect operation of the device. The Special Controls are silent on what would constitute appropriate levels of evidence necessary to satisfy this criterion. analytical, clinical and stability).
FDA Law Blog
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).
Aspiring Minority Doctor
FEBRUARY 7, 2023
It made me feel so special and loved. Food is extremely expensive in Bora Bora, so I am so grateful for the room credit that this retreat provided, because just getting a burger, salad, and dessert was over $100. Even cooler, the photographer took individual headshots of us that will be able to use for branding or however we like.
FDA Law Blog
MAY 4, 2023
In a DCT, trial-related activities may occur in trial participants’ homes, at local health care providers’ offices, or in local clinical laboratories. With regard to clinical trial visits and activities, the draft guidance provides examples of the types of approaches that may be possible with a DCT.
FDA Law Blog
MAY 8, 2023
FDA recommends that PCCPs specify only a “limited number” of modifications but does not provide a limit on the number of modifications that can be included. If the proposed performance evaluation methods are different from the original methods used, the manufacturer should describe the differences and provide a justification for the changes.
Expert insights. Personalized for you.
130 
Let's personalize your content